Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析

◆英語タイトル:Theralase Technologies Inc (TLT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME82122FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development of laser-based non-invasive therapeutic devices (laser systems) used for the reduction of chronic knee pain, inflammation, and accelerate tissue healing for numerous nerve, muscle, and joint conditions. Theralase’s photo dynamic therapy is dedicated on the discovery and development of small, light-activated photo dynamic compounds (PDC’s) and their associated drug formulations based on its proprietary non-immunosuppressive photodynamic technology targeting cancer cells, bacterial infections, and promote microbial sterilization. The company markets its products through a network of distributors in Canada, the US and internationally. Theralase Technologies is headquartered in Toronto, Ontario, Canada.

Theralase Technologies Inc Key Recent Developments

Mar 29,2021: Theralase launches anti-cancer therapy research centre
Jan 22,2021: Theralase expands intellectual property portfolio
Aug 28,2020: Theralase release 2Q2020 financial statements
Jun 30,2020: Theralase announces management information circular and annual general meeting postponement due to COVID-19
May 29,2020: Theralase release 1Q2020 financial statements

This comprehensive SWOT profile of Theralase Technologies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Theralase Technologies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Theralase Technologies Inc – Key Information
Theralase Technologies Inc – Overview
Theralase Technologies Inc – Key Employees
Theralase Technologies Inc – Key Employee Biographies
Theralase Technologies Inc – Key Operational Heads
Theralase Technologies Inc – Major Products and Services
Theralase Technologies Inc – History
Theralase Technologies Inc – Company Statement
Theralase Technologies Inc – Locations And Subsidiaries
Theralase Technologies Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Theralase Technologies Inc – Business Description
Theralase Technologies Inc – Corporate Strategy
Theralase Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
Theralase Technologies Inc – Strengths
Theralase Technologies Inc – Weaknesses
Theralase Technologies Inc – Opportunities
Theralase Technologies Inc – Threats
Theralase Technologies Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Theralase Technologies Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Theralase Technologies Inc, Key Information
Theralase Technologies Inc, Key Ratios
Theralase Technologies Inc, Share Data
Theralase Technologies Inc, Major Products and Services
Theralase Technologies Inc, History
Theralase Technologies Inc, Key Employees
Theralase Technologies Inc, Key Employee Biographies
Theralase Technologies Inc, Key Operational Heads
Theralase Technologies Inc, Other Locations
Theralase Technologies Inc, Subsidiaries
Theralase Technologies Inc, Key Competitors
Theralase Technologies Inc, SWOT Analysis
Theralase Technologies Inc, Ratios based on current share price
Theralase Technologies Inc, Annual Ratios
Theralase Technologies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oasmia Pharmaceutical AB (OASM):企業の財務・戦略的SWOT分析
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops, manufactures, markets and sells drugs for human and veterinary oncology. The company’s pipeline for human health includes apealea (paclical), currently at registration and approval stage, for treating …
  • Tieto Corp (TIETO):企業の財務・戦略的SWOT分析
    Tieto Corp (TIETO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Adamis Pharmaceuticals Corp (ADMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Vinci Construction UK Ltd:企業の戦略・SWOT・財務情報
    Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Viasat Inc:企業の戦略・SWOT・財務分析
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Synlogic Inc (SYBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Synlogic Inc (Synlogic), formerly TMC Therapeutics Inc is a clinical stage drug development company that develops novel class of living medicines for the treatment of rare and genetic metabolic diseases, by applying synthetic biology to probiotics. The company’s pipeline includes SYNB1020 a …
  • Boehringer Ingelheim GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biophar …
  • Banco Pan S.A. (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan S.A. (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務情報
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Parex Resources Inc (PXT):企業の財務・戦略的SWOT分析
    Summary Parex Resources Inc (Parex) is an oil and gas exploration and development company. The company acquires, explores, develops and produces crude oil and natural gas in South America and the Caribbean. It holds interests in onshore blocks in Magdalena Basins and Colombia's Llanos. Its explorati …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • State Atomic Energy Corporation Rosatom:電力:M&Aディール及び事業提携情報
    Summary State Atomic Energy Corporation Rosatom (ROSATOM) is the Russian Federation national nuclear corporation. It provides a wide range of services in the nuclear production chain, from uranium exploration and mining, uranium conversion and enrichment, nuclear fuel fabrication, mechanical enginee …
  • Kartonsan Karton Sanayi ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • SCIO Health Analytics:企業の戦略的SWOT分析
    SCIO Health Analytics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Heron Therapeutics Inc (HRTX):医療機器:M&Aディール及び事業提携情報
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-base …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Husky Energy Inc (HSE)-石油・ガス分野:企業M&A・提携分析
    Summary Husky Energy Inc. (Husky) is an integrated oil and gas company. The company has operations in upstream and downstream sectors of oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen and natural gas. Husky also carried out …
  • Cobra Electronics Corporation:企業の戦略的SWOT分析
    Cobra Electronics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆